| Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users L Wang, JE Min, E Krebs, E Evans, D Huang, L Liu, YI Hser, B Nosyk International Journal of Drug Policy 49, 32-40, 2017 | 117 | 2017 |
| The costs of crime during and after publicly funded treatment for opioid use disorders: a population‐level study for the state of California E Krebs, D Urada, E Evans, D Huang, YI Hser, B Nosyk Addiction 112 (5), 838-851, 2017 | 55 | 2017 |
| Ending the HIV epidemic in the USA: an economic modelling study in six cities B Nosyk, X Zang, E Krebs, B Enns, JE Min, CN Behrends, C Del Rio, ... The Lancet HIV 7 (7), e491-e503, 2020 | 54 | 2020 |
| Cost-effectiveness of publicly funded treatment of opioid use disorder in California E Krebs, B Enns, E Evans, D Urada, MD Anglin, RA Rawson, YI Hser, ... Annals of internal medicine 168 (1), 10-19, 2018 | 50 | 2018 |
| The Impact of Localized Implementation: Determining the Cost-Effectiveness of HIV Prevention and Care Interventions Across Six United States Cities E Krebs, X Zang, B Enns, JE Min, C Behrends, C Del Rio, JC Dombrowski, ... AIDS 34 (3), 447-458, 2020 | 45 | 2020 |
| Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study B Nosyk, X Zang, JE Min, E Krebs, VD Lima, MJ Milloy, J Shoveller, ... The lancet HIV 4 (7), e303-e310, 2017 | 44 | 2017 |
| The potential epidemiological impact of coronavirus disease 2019 (COVID-19) on the human immunodeficiency virus (HIV) epidemic and the cost-effectiveness of linked, opt-out HIV … X Zang, E Krebs, S Chen, M Piske, WS Armstrong, CN Behrends, ... Clinical Infectious Diseases 72 (11), e828-e834, 2021 | 42* | 2021 |
| The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study A Borquez, L Beletsky, B Nosyk, SA Strathdee, A Madrazo, D Abramovitz, ... The Lancet Public Health 3 (9), e429-e437, 2018 | 42 | 2018 |
| Developing a dynamic HIV transmission model for 6 US cities: an evidence synthesis E Krebs, B Enns, L Wang, X Zang, D Panagiotoglou, C Del Rio, ... PloS one 14 (5), e0217559, 2019 | 40 | 2019 |
| “Ending the epidemic” will not happen without addressing racial/ethnic disparities in the United States human immunodeficiency virus epidemic B Nosyk, E Krebs, X Zang, M Piske, B Enns, JE Min, CN Behrends, ... Clinical Infectious Diseases 71 (11), 2968-2971, 2020 | 34 | 2020 |
| Development and calibration of a dynamic HIV transmission model for 6 US cities X Zang, E Krebs, JE Min, A Pandya, BDL Marshall, BR Schackman, ... Medical Decision Making 40 (1), 3-16, 2020 | 31 | 2020 |
| Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs? B Nosyk, E Krebs, O Eyawo, JE Min, R Barrios, JSG Montaner Current HIV/AIDS Reports 11, 468-478, 2014 | 29 | 2014 |
| Dynamics in the costs of criminality among opioid dependent individuals E Krebs, T Kerr, J Montaner, E Wood, B Nosyk Drug and alcohol dependence 144, 193-200, 2014 | 28 | 2014 |
| Increased drug use and the timing of social assistance receipt among people who use illicit drugs E Krebs, L Wang, M Olding, K DeBeck, K Hayashi, MJ Milloy, E Wood, ... Social Science & Medicine 171, 94-102, 2016 | 26 | 2016 |
| Ending the epidemic in America will not happen if the status quo continues: modeled projections for human immunodeficiency virus incidence in 6 US cities B Nosyk, X Zang, E Krebs, JE Min, CN Behrends, C Del Rio, ... Clinical Infectious Diseases 69 (12), 2195-2198, 2019 | 25 | 2019 |
| Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study L Wang, E Krebs, JE Min, WC Mathews, A Nijhawan, C Somboonwit, ... The Lancet HIV 6 (8), e531-e539, 2019 | 24 | 2019 |
| Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder E Krebs, T Kerr, E Wood, B Nosyk Journal of substance abuse treatment 67, 30-37, 2016 | 23 | 2016 |
| Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia … M Piske, T Thomson, E Krebs, N Hongdilokkul, J Bruneau, S Greenland, ... BMJ open 10 (9), e036102, 2020 | 21 | 2020 |
| The costs of crime associated with stimulant use in a Canadian setting B Enns, E Krebs, K DeBeck, K Hayashi, MJ Milloy, L Richardson, E Wood, ... Drug and alcohol dependence 180, 304-310, 2017 | 21 | 2017 |
| Cost-effectiveness analysis in implementation science: a research agenda and call for wider application E Krebs, B Nosyk Current HIV/AIDS Reports 18, 176-185, 2021 | 20 | 2021 |
Xiao ZangUniversity of MinnesotaVerified email at umn.edu
